Clinical Evidence
254 results
HDx therapy enabled by Theranova
Expanded hemodialysis as effective alternative to on-line hemodiafiltration: A randomized mid-term clinical trial
HDx therapy enabled by Theranova
Expanded hemodialysis reduces the concentration of free light chains in patients with acute kidney injury in myeloma cast nephropathy
HDx therapy enabled by Theranova
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling
HDx therapy enabled by Theranova
Expanded hemodialysis: a new concept of renal replacement therapy
HDx therapy enabled by Theranova
Expanded hemodialysis: is anticoagulation of the dialysis circuit different from online hemodiafiltration and high-flux hemodialysis?
HDx therapy enabled by Theranova
Experience of using haemodialysis with medium cut-off dialyser in cast nephropathy
HDx therapy enabled by Theranova
Exploratory comparison of dialysis efficiency at different dialysate flow (Qd) in expanded hemodialysis in two centers in Colombia
HDx therapy enabled by Theranova
Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules
HDx therapy enabled by Theranova
Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules
HDx therapy enabled by Theranova
Extended versus conventional hemodialysis view or online hemodiafiltration. Comparative study of the need for heparin and coagulation of the system (enfermerianefrologica.com)
HDx therapy enabled by Theranova
Extracorporeal light-chain elimination in myeloma with simple medium cutoff membrane hemodialysis: a retrospective cohort study
Vantive is a trademark of Vantive Health LLC or its affiliates.